by The Tutu Team | Sep 4, 2017 | Uncategorized
Author: PBR Staff Writer / Source: Let Life Happen From: pharmaceutical-business-review.com Pfizer, along with Alliance Foundation Trials (AFT) and six other international cancer research groups, has commenced a phase 3 clinical study to assess palbociclib... 
by The Tutu Team | Apr 6, 2017 | Uncategorized
Source: Breast Cancer Research Foundation Science News CDK4/6 inhibitors are a new class of drugs that have shown promise in the treatment of advanced ER- positive breast cancer. Cyclin dependent kinases (CDK) regulate the process of cell division, required for... 
by The Tutu Team | Apr 3, 2017 | Uncategorized
Author: Shobhit Seth / Source: Investopedia U.S. pharmaceutical giant Pfizer Inc. (PFE ) announced that it has secured approval from the U.S. Food And Drug Administration (FDA) for a supplemental New Drug Application (sNDA) for its first-in-class cyclin... 